| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q3 2013 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Vanguard Growth | 40 | Q3 2023 | 10.6% |
| Vanguard Value | 40 | Q3 2023 | 10.4% |
| Vanguard European | 40 | Q3 2023 | 9.2% |
| Vanguard FTSE Pacific | 40 | Q3 2023 | 5.9% |
| iShares S&P Midcap 400 Value | 40 | Q3 2023 | 4.8% |
| iShares S&P Midcap 400 Growth | 40 | Q3 2023 | 3.4% |
| SPDR S&P 500 | 40 | Q3 2023 | 2.7% |
| Unitedhealth Group Inc | 40 | Q3 2023 | 2.0% |
| iShares Barclays MBS Bond | 40 | Q3 2023 | 2.1% |
| Exxon Mobil Corp | 40 | Q3 2023 | 2.4% |
View Blue Edge Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-15 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-21 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-10 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Blue Edge Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.